Dr Morepen Ltd, the FMHG (fast moving health goods) subsidiary of the Rs 430 crore Morepen Laboratories Ltd, has adopted a three-pronged strategy to take on the gastro category with its Dab brand of products. It intends to add two new products to the Dab umbrella by April. These will be Dab Tab (digestive tablets) and Dab Gel (digestive syrups) in various flavours such as orange and mint. The aim is to touch Rs 8 crore sales with Dab.
It already has an anti-acid, Dab Fizz in powder form. This is available in two flavours
